Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pharming Group N.V.
DescriptionRecombinant human fibrinogen
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationBleeding
Indication DetailsTreat bleeding in fibrinogen deficient patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today